StockNews.AI
ESTA
StockNews.AI
12 days

Establishment Labs Reports Second Quarter 2025 Financial Results

1. ESTA reported Q2 revenue of $51.3 million, up 16.3% year-over-year. 2. Motiva sales contributed $10.3 million to overall revenue growth.

Earnings
-16.58%Current Return
VS
+0.71%S&P 500
$41.7908/07 08:12 AM EDTEvent Start
$34.8608/08 02:59 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The 16.3% revenue growth reflects strong market demand and potential for further gains, similar to past trends where consistent revenue increases led to stock price appreciation.

How important is it?

The reported revenue growth directly influences investor perception and market sentiment, making it highly relevant to ESTA's stock performance.

Why Short Term?

Positive earnings reports tend to have immediate effects on stock prices, as seen in prior quarterly reports where strong earnings resulted in upward price momentum for ESTA.

Related Companies

ABTMDTSYK
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2025. Second Quarter Highlights and Outlook (Unaudited) Second quarter worldwide revenue of $51.3 million, an increase of 16.3% from the year ago period. Revenue included $10.3 million of Motiva sales in the Un.

Related News